Successful administration of BI 695501, an adalimumab biosimilar, using an autoinjector (AI): results from a Phase II open-label clinical study (VOLTAIRE((R))-RL) - Cohen, S; Klimiuk, P A; Krahnke, T (Expert Opin Drug Deliv, 2018)
et al.